Is all cancer therapy immunotherapy?

Area of Science:

• Oncology
• Immunology
• Pharmacology

Background:

• Standard chemotherapies are widely used cancer treatments.
• Targeted immunotherapies represent a significant advancement in cancer care.
• The synergistic potential between chemotherapy and immunotherapy requires deeper exploration.

Purpose of the Study:

• To investigate the mechanisms by which standard chemotherapies enhance the efficacy of targeted immunotherapeutic agents.
• To provide a foundation for developing improved combination cancer therapies.

Main Methods:

• This study synthesitsizes current research findings.
• It focuses on preclinical and clinical evidence of drug interactions.

Main Results:

• Chemotherapy can modulate the tumor microenvironment, making it more susceptible to immune attack.
• Specific chemotherapy regimens have shown to potentiate the effects of various immunotherapeutic drugs.

Conclusions:

• Renewed research efforts are essential to fully elucidate these enhancing effects.
• Understanding these interactions will pave the way for more effective and personalized cancer treatment protocols.